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Abstract: Bacterial outer membrane proteins, along with a filling lipid molecule can be 
modified to form stable self-assembled monolayers on gold. The transmembrane domain 
of Escherichia coli outer membrane protein A has been engineered to create a scaffold 
protein to which functional motifs can be fused. In earlier work we described the assembly 
and structure of an antibody-binding array where the Z domain of Staphylococcus aureus 
protein  A  was  fused  to  the  scaffold  protein.  Whilst  the  binding  of  rabbit  polyclonal 
immunoglobulin G (IgG) to the array is very strong, mouse monoclonal IgG dissociates 
from the array easily. This is a problem since many immunodiagnostic tests rely upon the 
use  of  mouse  monoclonal  antibodies.  Here  we  describe  a  strategy  to  develop  an  
antibody-binding array that will bind mouse monoclonal IgG with lowered dissociation 
from the array. A novel protein consisting of the scaffold protein fused to two pairs of Z 
domains separated by a long flexible linker was manufactured. Using  surface plasmon 
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resonance the self-assembly of the new protein on gold and the improved binding of mouse 
monoclonal IgG were demonstrated. 
Keywords: membrane protein; gold; immunoglobulin; self-assembled monolayer; surface 
plasmon resonance 
 
1. Introduction 
Protein  arrays  are  becoming  increasingly  important.  They  have  uses  in  biosensors,  tissue 
engineering and proteomics. There are many challenges in developing new protein arrays and one 
direction  of  research  is  the  coupling  of  array  technology  with  the  well  established  and  described 
deposition of self-assembling monolayers (SAM) on gold [1]. Simple organic molecules with a thiol 
functional group can be immobilised to gold via a gold-thiolate bond, providing for the facile preparation 
of  well  characterised  stable  orientated  layers  on  smooth  surfaces  [2].  Peptides  and  proteins  with  
thiol-containing cysteine residues in their amino acid sequence can be included into mixed SAM on 
gold creating functional protein arrays [3,4] and membrane proteins are especially suitable since they 
naturally assemble into layers [5]. Membrane proteins with a β-barrel structure are particularly well 
suited to immobilisation as they can be specifically immobilised to a gold surface with a controlled 
orientation, retain their structure and function once immobilised and can be engineered to perform 
different functions [6]. 
Outer membrane protein A (OmpA) from Escherichia coli is a bacterial outer membrane protein 
with an N-terminal 8-stranded β-barrel transmembrane domain and a soluble C-terminal periplasmic 
binding domain [7,8]. The transmembrane domain of OmpA (tmOmpA) has formed the basis of a 
scaffold for inclusion in SAMs on gold. The tmOmpA has been engineered such that there is a cysteine 
residue for gold immobilisation in a periplasmic turn. Furthermore it has also been circularly permuted 
(ctOmpA) so that the N and C termini are exposed at the membrane surface allowing the addition of 
protein domains/motifs. Previously we have described fusing the Z domain of Staphylococcus aureus 
protein  A  to  the  N-terminus  of  ctOmpA  (ZZctOmpA)  [9].  The  Z  domain  binds  immunoglobulin  
G (IgG) at its constant region leaving the variable regions still free to bind antigen. The structure of 
ZZctOmpA in solution and surface immobilisation has been investigated [9,10]. Neutron reflectivity 
revealed that gold surface bound ZZctOmpA retained its structure when surrounded by a thioalkane 
filling molecule and that bound IgG was most likely to be in an upright conformation. Whilst an array 
of ZZctOmpA binds rabbit polyclonal IgG very tightly, mouse monoclonal IgG dissociates from the 
array more readily [10]. This is a problem because mouse monoclonals provide the specificity for a 
single epitope and are commonly used in immunodiagnostic assays as the primary capture antibody. In 
this paper we describe a novel strategy to reduce the dissociation of mouse monoclonal IgG2a from a 
membrane protein array and increase binding. We have shown that the stoichiometry of surface bound 
ZZctOmpA and IgG is one to one [10]. A single IgG molecule has two Z domain binding regions: one 
per heavy chain. To reduce the dissociation rate constant we aim to occupy both Z domain binding 
regions simultaneously using a linker system where a tandem pair of Z domains is linked by a flexible 
polypeptide  linker  to  another  Z  domain  pair  which  is  then  fused  to  ctOmpA  (ZZlinkZZctOmpA) Int. J. Mol. Sci. 2011, 12                       
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(Figure 1). The creation of the ZZlinkZZctOmpA can have two outcomes for IgG binding: either one 
IgG will bind per array protein as described above or the signal from the array will be increased due to 
an  increased  capacity  for  IgG  binding  from  the  simultaneous  binding  of  two  IgGs.  The  proposed 
polypeptide linker is a repeat of GGGGS. This type of linker was chosen as the small residues are less 
likely to interfere with other protein domains, it has a flexible random coil structure and the serine 
residue provides aqueous solubility [11]. Glycine-serine linkers have successfully been used by others 
to link antibody and hormone fragments [12,13] and for linking N and C termini of proteins in circular 
permutation [14].  
Figure 1. A schematic of ZZlinkZZctOmpA array protein. (a) A cartoon of the 5’ prime to 
3’ prime sequence showing each part of the protein; and (b) A model of the array proteins 
on gold. The protein graphics were made in SWISS PDB viewer [21] using PDB files 
1QJP for OmpA [8] and 1N2Q for the Z domains [22]. The ctOmpA part is in blue and the 
Z domains in red. The linker region is in green and is shown as unstructured. The filling 
molecule is also shown and is not a true representation of its packing. 
 
2. Results and Discussion 
2.1. Cloning 
The  gene  encoding  the  ZZlinkZZctOmpA  protein  was  constructed  in  stages.  First  a  DNA  
segment encoding the linker sequence was synthesized by Epoch Biolabs (Sugar Land, Texas, USA) 
and  supplied  cloned  into  vector  pBSK4D5F.  Second,  the  linker  sequence  was  PCR-amplified  
using  primers  Orla189F  (5'-GATCCTCGAGCGGTGGGGGCGGTT-3')  and  Orla190R  
(5'-GATCGTCGACTCAC CACCACCGCCTGAA-3'). The amplification was cloned into the Xho I 
site  of  plasmid  pORLA76  [10],  to  create  the  linkXXctOmpA  construct  (named  pORLA81).  
Finally,  the  region  encoding  a  tandem  pair  of  Z  domains  was  PCR-amplified  from  plasmid  Int. J. Mol. Sci. 2011, 12                       
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pEZZ18  [15]  using  primers  Orla1F  (5'-GGGAGACCACAACGG-3')  and  Orla166R  
(5'-CCATGTCGACGTGCTCGAATTCGCGTCTAC-3')  and  cloned  into  the  unique  Xho  I  site  of 
pORLA81 to create the gene encoding ZZlinkZZctOmpA (named pOrla82). At each stage, the clones 
with  the  desired  insertion  in  the  correct  orientation  were  identified  by  analytical  PCR,  restriction 
digestion and gel electrophoresis. pORLA82 was verified by DNA sequencing.  
2.2. Purification of Inclusion Bodies and Refolding 
The ZZlinkZZctOmpA protein encoded on pORLA82 was expressed as inclusion bodies in E. coli 
BLR cells which have the recA
- mutation that prevents recombination between stretches of identical 
DNA sequence such as the regions encoding the Z domains on pORLA82. The inclusion bodies were 
purified in 8 M urea first by immobilised metal affinity, and then by anion exchange, chromatography. 
A concentrated sample of protein in urea was slowly diluted into refold buffer with stirring and left to 
refold for 96 hours at 37 °C. The refolding was confirmed by band shifts on SDS-PAGE (not shown) 
and CD spectroscopy (Figure 2). The CD data clearly shows that there is more α-helix structure in 
ZZlinkZZctOmpA and that the protein is also folded. At over 50 kDa this is a comparatively large 
protein and with a flexible linker. Previous linkers have only used a single tandem repeat of gly-ser or 
a triple repeat of GGGGS. The ZZlinkZZctOmpA has a sextuple repeat of GGGGS, which, to our 
knowledge is the largest repeat of this type of linker successfully cloned, purified and refolded into a 
functional structure for an engineered protein. Long peptide linkers contain proline residues in their 
sequence  which,  due  to  having  no  amide  hydrogen  to  form  hydrogen  bonds,  suppress  secondary 
structure [16]. However the presence of proline is undesirable in this case as it would add a structural 
rigidity that would impinge on IgG binding. Charged residues are also left out of the linker structure to 
avoid unwanted interactions between the linker and the IgG molecule.  
Figure  2.  Circular  dichroism  spectroscopy  of  folded  ZZlinkZZctOmpA  (red  trace)  at  
0.20 mg mL
−1. 
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The CD spectrum of ZZctOmpA (black trace) at 0.24 mg mL
−1 is shown for comparison. Spectra 
were taken from 250 nm to 190 nm at a HT of less than 600 V using a 0.02 cm pathlength cuvette. Int. J. Mol. Sci. 2011, 12                       
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2.3. Self-Assembly on Gold 
ZZlinkZZctOmpA can assemble onto gold via the thiol group of the single cysteine residue in one 
of  the  periplasmic  turns  of  ctOmpA.  The  surface  assembly  was  measured  using  surface  plasmon 
resonance (SPR). Three depositions of ZZlinkZZctOmpA were carried out leading to a total increase 
of 995 Response Units (RU) which equates to 1.18 × 10
10 molecules mm
−2 deposited onto the gold 
surface (Figure 3) (assuming 1 RU equates to 1 pg mm
−2 of protein immobilised to the gold surface [17]). 
A 1% (w/v) SDS wash was used between each deposition to remove non-specifically bound protein. 
The total response equates to a surface coverage of 9.6%. The remaining surface was covered with a 
filling molecule which was a lipid-mimic, 1-mercaptoundec-11-yltriethylene glycol (thioPEG). The 
polyethyl glycol head group of the filling is resistant to non-specific protein adsorption [18] ensuring 
that any subsequent protein additions to the array will only bind via ZZlinkZZctOmpA. The assembly 
of the array is similar to that previously observed for protein immobilisation on gold. The surface 
coverage achieved is of the same magnitude as that reported for the engineered E. coli porin OmpF 
E183C [5] as well as ctOmpA and ZZctOmpA  [10]. Removal of protein from the surface by the 
addition of thioPEG is unlikely due to the strong gold-thiolate bond between the surface and the thiol 
group of the cysteine residue. Significant protein removal has not been previously observed for other 
membrane proteins on gold by neutron reflection [10,19]. 
Figure 3. SPR trace of the assembly of ZZlinkZZctOmpA on gold. The assembly was 
carried out on a BIAcore X instrument using Au sensor chips. 25 µL of ZZlinkZZctOmpA 
(0.20 mg mL
−1) was injected in to the flow cell at 5 µL min
−1. Each protein injection was 
followed with an injection of 1% SDS at 5 µL min
−1 to remove any non-specifically bound 
protein. After protein depositions a filling molecule, thioPEG was deposited. ThioPEG at 
0.25 mg mL
−1 in a solution of 1% OG 10 mM Tris-HCl pH 8.0 and 1 mM TCEP was 
injected into the flow cell at 5 µL min
−1. As with the protein depositions each injection was 
followed by a 1% SDS wash to remove non-specifically bound material. The unlabelled 
sections of the trace are a PBS buffer wash. 
 Int. J. Mol. Sci. 2011, 12                       
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2.4. Antibody Binding 
Figure  4(a)  shows  typical  binding  of  30  µg  mL
−1  rabbit  polyclonal  IgG  to  an  array  of 
ZZlinkZZctOmpA with 2580 RU of bound IgG in this case, which is a similar level of binding to an 
array ZZctOmpA with 1955 RU. With both arrays there is very little dissociation of rabbit polyclonal 
IgG  during  the  PBS  wash.  The  ZZlinkZZctOmpA  array  also  bound  mouse  monoclonal  IgG2a  
(Figure 4(b)) with a total of 2258 RU bound at the end of the antibody injection. The bound mouse 
monoclonal IgG still retained the ability to bind antigen, which in this case was human serum albumin 
(HSA). A total of 676 RU of HSA was bound to the array in Figure 4(b), which corresponds to 33% of 
the available antigen binding sites being filled. The lack of saturation of the bound monoclonal IgG 
could be due to the dissociation of the IgG from the array during the antigen association.  
Figure 4. Comparing antibody binding between arrays of ZZctOmpA (black traces) and 
ZZlinkZZctOmpA  (red  traces).  The  arrays  were  assembled  as  in  Figure  2  and  IgG  at  
30 µg mL
−1 in PBS was flowed over the arrays at 2 µL min
−1. After the antibody injection 
PBS running buffer was flowed over the array to measure the dissociation of antibody 
from the array. 0.1 mg mL
−1 HSA was injected at 2 µL min
−1. (a) The binding of rabbit 
polyclonal IgG; and (b) Mouse monoclonal anti-HSA IgG2a binding. 
 
Previously, using an array of ZZctOmpA mouse monoclonal IgG2a dissociated from the array more 
readily than rabbit polyclonal  IgG [10]. By  analysing the binding of a range of concentrations of 
mouse  monoclonal  IgG2a  over  an  array  of  ZZctOmpA  and  ZZlinkZZctOmpA  it  appears  that  the 
dissociation rate of antibody from the two arrays is similar (Figure 5). However the binding capacity of 
the ZZlinkZZctOmpA array is larger. This could be due to increasing the stoichiometry between the 
array protein and antibody i.e. two IgG molecules are binding to one ZZlinkZZctOmpA molecule.  
An explanation for this may come from small angle X-ray scattering (SAXS) of blue fluorescent 
protein and green fluorescent protein linked by either 3× or 4× GGGGS which showed that the linker 
mainly adopted a compact structure and that this structure could have been driven by protein-protein 
interactions between the two fluorescent proteins [20]. The SAXS data also showed that the linkers Int. J. Mol. Sci. 2011, 12                       
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were flexible enough to reach a maximum extension of 120 Å. Assuming an average amino acid length 
in a polypeptide chain of 3.5 Å then this would mean that the length of our GGGGS sextuplet linker 
would be 135 Å (length of linker plus one Z domain) which would be enough to span the Fc fragment 
of the IgG molecule and still allow for steric hindrances and van der Waals interactions. However if 
the linker is adopting a range of conformations from compact to extended then this may drive an 
increased  capacity  for  multiple  IgG  binding  rather  than  simultaneous  binding  of  both  Z  domain 
binding regions on a single IgG. 
Figure 5. The binding of mouse monoclonal IgG2a to an array of ZZlinkZZctOmpA (solid 
traces)  and  ZZctOmpA  (dashed  traces)  over  a  range  of  antibody  concentrations.  The 
antibody concentrations used were 480 nM (black), 40 nM (red) and 5 nM (green). A PBS 
only injection is also shown with 0 RU response. The antibody in PBS was flowed over the 
array at 10 µL min
−1 and had a total contact time of 10 min before a dissociation time of  
20  min.  The  array  was  regenerated  with  100  mM  glycine  pH  2.0  between  each  
antibody injection. 
 
3. Experimental Details 
3.1. Materials 
All  chemical  reagents  were  purchased  from  Sigma-Aldrich  (Poole,  Dorset,  UK)  or  Melford 
Laboratories (Ipswich, Suffolk, UK) unless otherwise stated. Materials for molecular biology were 
from Promega or Fermentas. Columns for protein purification and gold surfaces for SPR were from 
GE Healthcare. Int. J. Mol. Sci. 2011, 12                       
 
5164
3.2. Molecular Biology 
Gene amplification was by polymerase chain reaction (PCR). The PCR mix consisted of 2.5 µL of 
10× reaction buffer, 1.0 µL of the forward and reverse primers at 100 µM concentration each, 2.5 µL 
of  2.5  mM  deoxynucleotide  triphosphates,  10  ng  of  template  DNA,  0.5  µL  of  Fermentas  DNA 
polymerase  and  water  to  make  the  volume  up  to  25  µL.  The  PCR  was  hot  started  at  95  °C  for  
30 seconds followed by 25 cycles of 95 °C for 30 seconds, 55 °C for 30 seconds and 68 °C for  
4 min. The PCR products were assessed for yield and purity on a 1% (w/v) agarose gel stained with 
0.05% ethidium bromide. The PCR products were purified and digested with restriction endonucleases 
using 1 unit of enzyme and relevant buffer. The plasmid vectors were linearised by cleavage with the 
Xho I enzyme and gel purified on a 1% agarose gel. Ligations were set up using molar ratios of 1:1, 
1:3, 1:5 and 1:0 of vector to insert. The ligations used the T4 DNA ligase and were left to incubate at  
4  °C  overnight.  The  ligation  products  were  then  transformed  into  chemically  competent  E.  coli  
XL1-blue cells and colonies picked and assessed for the presence of insert.   
3.3. Protein Expression, Purification and Refolding  
The ZZlinkZZctOmpA protein was expressed in E. coli BLR cells cultured at 37 °C in shaking 
flasks. Once the cells had reached an OD600 of ~0.6 protein expression was induced by the addition of 
IPTG at a final concentration of 1 mM. The cells were harvested once they had reached the stationary 
phase of  growth by centrifugation at 8000× g for 15 min and 4 °C. The cells were disrupted  by 
incubation  overnight  at  −20  °C  in  a  detergent  solution  of  Bugbuster  (Novagen,  Nottingham,  UK) 
(using 10 mL for every gram of wet cell pellet) which was supplemented with DNase, RNase and 
lysozyme. The inclusion bodies were isolated by centrifugation at 12,000× g for 20 min and washed 
three times by homogenisation in a 1 in 10 dilution of Bugbuster in deionised water followed by 
centrifugation at 12,000× g for 20 min. The inclusion bodies were then solubilised in 8 M urea, 20 mM 
sodium phosphate pH 7.6, 500 mM NaCl and 20 mM imidazole. The proteins were column purified 
using an ÄKTA Prime FPLC system firstly by immobilised metal affinity chromatography (IMAC) 
using a HisTrap FF 1 mL nickel (II) ion column with elution typically in 15 mL of 250 mM imidazole, 
8 M urea, 20 mM sodium phosphate pH 7.6 and 500 mM NaCl. The His6-tagged protein containing 
fractions were pooled, concentrated to a volume of 2.5 mL and then buffer-exchanged into 8 M urea, 
30 mM ethanolamine pH 9.5 and 1 mM DTT using a PD10 column. The proteins were further purified 
using a 1 mL HiTrap Sepharose Q FF column using a 0 to 1 M NaCl gradient with elution of the 
protein typically at 120 mM NaCl. Pure protein fractions were concentrated to a volume of 1 mL using 
a Vivaspin 10,000 molecular weight cut-off spin concentrator. The proteins were refolded by slowly 
diluting the protein plus urea into refold buffer (20 mM Tris-HCl pH 8.0, 1% (w/v) n-octyl-β-D-
glucopyranoside (OG), 0.1 mM EDTA and 1 mM DTT) by 1 in 10 and left to incubate for 72 hs at  
37 °C to allow for complete refolding. Residual urea was removed by buffer exchange using a PD10 
column equilibrated with refold buffer with 1 mM TCEP replacing DTT. Int. J. Mol. Sci. 2011, 12                       
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3.4. Circular Dichroism 
Circular Dichroism spectroscopy was carried out using 0.02 cm pathlength demountable cuvettes in 
a Jasco J-810 spectropolarimeter. The protein concentration was determined by protein absorbance at 
280 nm and circular dichroism was scanned from 250 nm to 185 nm ten times, averaged and a buffer 
blank was subtracted. The circular dichroism was expressed as ∆ε (M
−1 cm
−1). 
3.5. Surface Plasmon Resonance 
Au sensor chips were used for SPR experiments which have a bare gold surface deposited onto an 
optical slide. The gold surface of the chip was cleaned by incubation for 15 min in an acid piranha 
solution (70% (v/v) concentrated sulphuric acid 30% (v/v) hydrogen peroxide). The surface was then 
cleaned  with  1%  (v/v)  Hellmanex  (Hellma  UK,  Southend  on  Sea,  Essex,  UK)  and  rinsed  with 
deionised water. The chip surface was passivated by 1% (v/v) BME solution in ethanol for 10 min 
followed by washing with 1% (w/v) SDS and distilled water.  
The  filling  molecule,  1-mercaptoundec-11-yltriethylene  glycol  (thioPEG)  (Prochmia  Surfaces, 
Sopot, Poland) was diluted in a solution of 1% (w/v) OG, 20 mM Tris-HCl pH 8.0 and 1 mM TCEP, 
heated to 50 °C before deposition to ensure complete dissolution. To prepare the protein and filling 
molecule for deposition on gold and ensure that all disulphides were broken, TCEP reducing agent was 
added to the protein and the filling molecules at a final concentration of 1 mM and incubated at room 
temperature for 10 min prior to deposition.  
A two channel BIAcore X instrument was used for experiments. The protein was injected in a 
typical volume of 50 µL at a flow rate of 5 µL min
−1 followed by injections of 1% (w/v) SDS to 
remove non-specifically bound protein before the filling molecule, thioPEG, was deposited. Three 
times 50 µL of 0.25 mg mL
−1 thioPEG in a solution of 1% OG at a rate of 5 µL minute
−1 was used for 
each deposition, with a wash of 1% (w/v) SDS between each deposition to remove non-specifically 
bound thioPEG. Antibodies (IgG) and antigen (human serum albumin, HSA) were diluted in PBS and 
injected into the flow cell at a rate of 2 µL min
−1. The running buffer was phosphate buffered saline 
(PBS, 20 mM sodium phosphate pH 7.6, 137 mM NaCl and 2.7 mM KCl) and the regeneration buffer 
was 100 mM glycine pH 2.0. 
4. Conclusions 
A scaffold protein with immunoglobulin binding domains separated by a long flexible linker as the 
functional motif has been successfully produced and shown to form stable self-assembled monolayers 
on gold. Whilst the dissociation rate of mouse monoclonal IgG from the ZZlinkZZctOmpA is similar 
to ZZctOmpA, the introduction of a flexible linker between the Z domains increases the capacity for 
IgG binding resulting in an increase in signal and sensitivity from the array. 
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